SCHEMBL19088826

SCHEMBL19088826

C=Cc1ccc(CN(CCOC)Cc2ccc(C=C)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 1/20 0.38
HRH3 Q9Y5N1 2/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35
APLNR P35414 1/20 0.34
MAOB P27338 2/20 0.34
MAOA P21397 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.32
TAS1R1 Q7RTX1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14889166 0.97 MEN1 (0.47) MEN1KMT2AALDH1A1HRH3CHRNB2
SCHEMBL6390256 0.83 ALDH1A1 (0.50) ALDH1A1HRH3
SCHEMBL21132245 0.82 ALDH1A1 (0.34) MEN1KMT2AALDH1A1HRH3CHRNB2
SCHEMBL14889318 0.80 HRH3 (0.41) MEN1KMT2AALDH1A1HRH3CHRNB2
SCHEMBL18493213 0.79 ALDH1A1 (0.55) MEN1KMT2AALDH1A1HRH3CHRNB2
SCHEMBL21339590 0.77 MEN1 (0.34) MEN1KMT2AALDH1A1CHRNB2CHRNB4
SCHEMBL18493203 0.77 MAPT (0.56) ALDH1A1HRH3
SCHEMBL629044 0.77 MAPT (0.55) MEN1KMT2AALDH1A1HRH3MAOA
SCHEMBL610061 0.77 HRH3 (0.62) ALDH1A1HRH3
SCHEMBL20464231 0.77 HTT (0.46) MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019078827-A1 UV-CURABLE INKJET INKS HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2019-04-25 WO disclosed
WO-2017116272-A1 METHOD FOR PREPARING TERTIARY AMINES COMPRISING ETHYNYLBENZYL SUBSTITUENTS PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (RU) 2017-07-06 WO disclosed